Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Business Journal.
Press releases published on May 6, 2025
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
GlobeNewswire
·
May 6, 2025
Highlights First quarter 2025 revenue of $196 million declined by 3% year-over-year. Excluding headwinds1 of $16 million, revenue increased 5% year-over-year. First quarter 2025 Prenatal revenue grew 11% year-over-year, while Pharmacogenomics revenue …
Amwell makes grant to new employee under inducement plan
GlobeNewswire
·
May 6, 2025
BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading technology-enabled care platform provider, announced that on May 6, Amwell made a grant of RSUs of 3,451 shares of its Class A common stock to one new employee. The grant was offered …
Flywire Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
First Quarter Revenue Increased 17.0% Year-over-Year First Quarter Revenue Less Ancillary Services Increased 16.8% Year-over-Year Previous Fiscal Year 2025 guidance reaffirmed BOSTON, May 06, 2025 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“ …
SuRo Capital Corp. Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
SuRo Capital Portfolio Investment, CoreWeave, Completes Largest Tech IPO Since 2021 SuRo Capital Portfolio Investment, OpenAI, Closes Largest Venture Raise with $300 Billion Valuation Net Asset Value of $6.66 Per Share as of March 31, 2025 NEW YORK, May 06 …
Astera Labs to Share Vision for Expanding Opportunities in AI Infrastructure with UALink
GlobeNewswire
·
May 6, 2025
SANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Astera Labs, Inc. (Nasdaq: ALAB), a global leader in semiconductor-based connectivity solutions for AI and cloud infrastructure, today announced its upcoming webinar hosted by J.P. Morgan on Ultra …
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress
GlobeNewswire
·
May 6, 2025
CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study ongoing, dosed first three patients at 300 micrograms; data readout expected mid-2025 with dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to …
Key Tronic Corporation Announces Results for the Third Quarter of Fiscal Year 2025
GlobeNewswire
·
May 6, 2025
SPOKANE VALLEY, Wash., May 06, 2025 (GLOBE NEWSWIRE) -- Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing services (EMS), today announced its results for the quarter ended March 29, 2025. For the third quarter of fiscal year …
Nature's Sunshine Reports Strong First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
LEHI, Utah, May 06, 2025 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Nature’s Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the first quarter ended March 31, …
Weyco Reports First Quarter Sales and Earnings
GlobeNewswire
·
May 6, 2025
MILWAUKEE, May 06, 2025 (GLOBE NEWSWIRE) -- Weyco Group, Inc. (NASDAQ: WEYS) (“we,” “our,” “us” and the “Company”) today announced financial results for the quarter ended March 31, 2025. First Quarter 2025 Overview Net sales: $68.0 million (down 5% …
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2025
GlobeNewswire
·
May 6, 2025
SALT LAKE CITY, May 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third …
InnovAge Announces Financial Results for the Fiscal Third Quarter Ended March 31, 2025
GlobeNewswire
·
May 6, 2025
DENVER, May 06, 2025 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge” or the “Company”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare programs to frail, predominantly dual-eligible seniors through the Program of All- …
Clover Health Reports First Quarter 2025 Results and Improves Full Year 2025 Guidance
GlobeNewswire
·
May 6, 2025
First quarter 2025 Medicare Advantage membership of 103,418, up 30% year-over-year First quarter 2025 Total revenues of $462 million, up 33% year-over-year Medicare Advantage medical costs are in line with expectations, underscoring the strength of Clover’ …
Carlyle Secured Lending, Inc. Announces Financial Results For First Quarter Ended March 31, 2025, Declares Second Quarter 2025 Dividend of $0.40 Per Common Share
GlobeNewswire
·
May 6, 2025
NEW YORK, May 06, 2025 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, “we,” “us,” “our,” “CGBD” or the “Company”) (NASDAQ: CGBD) today announced its financial results for its first quarter ended March 31, …
Eos Energy Enterprises Records Highest Quarterly Revenue and Reports First Quarter 2025 Financial Results and Reaffirms 2025 Outlook
GlobeNewswire
·
May 6, 2025
$10.5 million quarterly revenue, highest in Company history as production ramps to deliver customer backlog Year-to-date shipments surpass full-year 2024 customer shipments with seven Z3 projects under installation and commissioning Successfully achieved …
Synchronoss Technologies Reports First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
First Quarter Revenue was $42.2 Million, Including 93.1% Recurring Revenue GAAP Gross Margin Expands to 70.4%; Adjusted Gross Margin Rises to 79.0% Closed $200 Million Term Loan Refinancing in April, Extending Debt Maturity Until 2029 Reaffirms All Full …
Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025
GlobeNewswire
·
May 6, 2025
IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2025 and raised its …
WW International, Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
May 6, 2025
Total End of Period Subscribers of 3.4 million, including 135 thousand End of Period Clinical Subscribers Revenues of $186.6 million, down 9.7% vs. prior year period, including Clinical Subscription Revenues of $29.5 million, up 57.1% vs. prior year period …
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDEND
GlobeNewswire
·
May 6, 2025
MONDOVI, Wis., May 06, 2025 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on June 27, …
Mercury Systems Reports Third Quarter Fiscal 2025 Results
GlobeNewswire
·
May 6, 2025
Q3 FY25 Bookings of $200.4 million; trailing-twelve-month book-to-bill of 1.1 Backlog of $1.34 billion; up 4% year-over-year Q3 FY25 Revenue of $211.4 million; GAAP net loss of $19.2 million; and adjusted EBITDA of $24.7 million Operating Cash Flow of $30. …
Keros Therapeutics Reports Recent First Quarter 2025 Financial Results
GlobeNewswire
·
May 6, 2025
LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients …